After totally screening, 42 patients (29 males, 13 females) were fulfilled with inclusion criteria (Fig. 1), of whom 13 (30.1%) died after 7 days. And further follow-up revealed a 28-day mortality rate as 42.9% (18/42). Table 1 shows there are no significant differences between the survivors and nonsurvivors in terms of baseline demographic and clinical characteristics. Comparison to nosurvivor group, at 24 hours after enrollment, the HR (97.27±22.07 vs. 120.20±20.56), EVLWI (7.32±2.96 vs. 15.9±11.2), and Lac (1.62±0.92 vs. 6.33±5.83) level in survivor group exhibits considerably lower (P < 0.05), whereas the CI and PaO2/FiO2 were higher (Table 2). Person correlation analysis revealed PaO2/FiO2 was negatively correlated with EVLWI (r = -0.673, P < 0.01) at 24 hours (Fig. 2), in addition Lac was found no correlation with CI.
Table 1. Demographic data and clinical characteristics according to survival at day 7
|
Survivors
(n=29)
|
Nonsurvivors
(n=13)
|
P value
|
Age (years)
|
63 ± 13
|
66 ± 17
|
0.572
|
Males, n (%)
|
19 (65.5)
|
13 (76.9)
|
0.086
|
APACHEⅡ
|
21 ± 3
|
25 ± 5
|
0.545
|
SOFA
|
11 ± 3
|
14 ± 3
|
0.152
|
Underlying disease, n(%)
|
|
|
|
Hypertension
|
11 (37.9)
|
7 (53.8)
|
0.272
|
Chronic cardiovascular disease
|
15 (51.7)
|
8 (61.5)
|
0.742
|
COPD
|
3 (10.3)
|
1 (7.6)
|
0.520
|
Chronic renal failure
|
4 (13.8)
|
4 (30.8)
|
0.221
|
Diabetes mellitus
|
4 (13.8)
|
5 (38.4)
|
0.182
|
Source of infection, n(%)
|
|
|
|
Lungs
|
15 (51.7)
|
9 (69.2)
|
0.284
|
Abdomen
|
11 (37.9)
|
3 (23.1)
|
0.709
|
Soft tissue
|
2 (6.9)
|
1 (7.7)
|
1.000
|
Other
|
1 (4.3)
|
0 (0)
|
0.485
|
APACHE II, Acute physiology and chronic health practical guidance system II; SOFA, Sequential Organ Failure Assessment; COPD, chronic obstructive pulmonary disease
Table 2. Comparison of hemodynamic parameters at beginning and 24 hours after enrollment between survivors and norsurvivos
Hemodynamic parameter
|
Time
|
Survivors
(n=29)
|
Nonsurvivors
(n=13)
|
t
|
P
|
HR
(bpm)
|
Baseline
|
123.73 ± 17.56
|
123.93 ± 28.97
|
0.320
|
0.751
|
24 h
|
97.27 ± 22.07
|
120.20 ± 20.56
|
−2.945
|
0.006
|
CI
(ml·s−1·m−2)
|
Baseline
|
3.89 ± 1.48
|
3.62 ± 1.80
|
0.445
|
0.660
|
24 h
|
3.67 ± 0.85
|
2.98 ± 0.73
|
2.395
|
0.024
|
EVLWI (ml·kg−1)
|
Baseline
|
8.98 ± 5.85
|
13.2 ± 7.39
|
−1.162
|
0.120
|
24 h
|
7.32 ± 2.96
|
15.9 ± 11.2
|
−2.870
|
0.008
|
SVI
(ml·m−2)
|
Baseline
|
31.67 ± 10.56
|
29.53 ± 13.95
|
0.472
|
0.640
|
24 h
|
41.31 ± 14.93
|
45.51 ± 66.09
|
−0.239
|
0.813
|
GEF
(%)
|
Baseline
|
17.80 ± 4.74
|
15.80 ± 5.34
|
1.084
|
0.228
|
24 h
|
19.40 ± 5.26
|
16.53 ± 5.29
|
1.488
|
0.148
|
GEDVI
(ml·m−2)
|
Baseline
|
764.46± 89.13
|
787.57 ± 330.30
|
−0.221
|
0.827
|
24 h
|
898.07± 34.99
|
754.31 ± 166.55
|
1.821
|
0.081
|
CVP
(cmH2O)
|
Baseline
|
9.80 ± 4.20
|
9.33 ± 2.38
|
0.375
|
0.710
|
24 h
|
9.33 ± 5.70
|
9.33 ± 2.74
|
0.000
|
0.740
|
SVRI (kPa·s·L−1·m−2)
|
Baseline
|
1602.13± 647.15
|
1706.27± 1011.97
|
−0.336
|
0.740
|
24 h
|
1789.07± 419.84
|
1515.87± 612.63
|
1.425
|
0.165
|
PVPI
|
Baseline
|
1.89 ± 0.94
|
2.43 ± 1.03
|
−1.498
|
0.145
|
24 h
|
1.30 ± 0.46
|
2.87 ± 1.89
|
−3.119
|
0.004
|
Lac
(mmol/L)
|
Baseline
|
5.61 ± 3.85
|
5.11 ± 2.94
|
0.385
|
0.703
|
24 h
|
1.62 ± 0.92
|
6.33 ± 5.83
|
−2.885
|
0.008
|
PaO2/FiO2 (mmHg)
|
Baseline
|
202.0 ± 148.0
|
233 ± 142.60
|
−0.584
|
0.564
|
24 h
|
242.8 ± 89.68
|
136.07 ± 78.01
|
3.478
|
0.002
|
BE
(mmol/L)
|
Baseline
|
−4.33 ± 4.72
|
−4.08 ± 6.92
|
−0.119
|
0.906
|
24 h
|
1.47 ± 2.64
|
−3.64 ± 6.99
|
2.650
|
0.013
|
HR, heart rate; CI, cardiac index; EVLWI, extravascular lung water index; SVI, stroke volume index;
GEF, global ejection fraction; GEDVI, global end-diastolic volume index; CVP, central venous pressure; SVRI, systemic vascular resistance index; PVPI, pulmonary vascular permeability index; BE, base excess
As shown in Table 3, the AUC-ROC of HR, EVLWI, PVPI, and Lac were 0.739, 0.776, 0.764, and 0.794. Compared to the single parameter, the combination of Lac and PaO2/FiO2 at 24 hours was superior for early prognosis. The AUC was 0.853, with a sensitivity of 83.3%, a specificity of 84.6%, and the Youden’ s Index of 0.679, as seen in Figure 3.
Table 3. The predictive value of hemodynamic parameters for early prognosis
Parameter
|
AUC
|
Critical value
|
Sensitivity
(%)
|
Specificity
(%)
|
Youden’s index
|
P
|
HR (24h)
|
0.739
|
116.5
|
66.7
|
86.7
|
0.534
|
0.007
|
CI (24h)
|
0.302
|
2.94
|
33.3
|
13.3
|
−0.534
|
0.065
|
EVLWI (24h)
|
0.776
|
9.2
|
53.3
|
86.7
|
0.534
|
0.010
|
PVPI (24h)
|
0.764
|
2.05
|
57.1
|
93.3
|
0.504
|
0.015
|
Lac (24h)
|
0.794
|
2.75
|
66.7
|
92.3
|
0.590
|
0.002
|
PaO2/FiO2 (24h)
|
0.171
|
141.0
|
33.3
|
70.0
|
−0.600
|
0.002
|
BE (24h)
|
0.267
|
−3.1
|
46.7
|
0.0.
|
0.533
|
0.029
|
HR, heart rate; CI, cardiac index; EVLWI, extravascular lung water index;
PVPI, pulmonary vascular permeability index; BE, base excess